bioRxivBiochemistryPreprint
An integrated method for single cell proteomics with simultaneous measurements of intracellular drug concentration implicates new mechanisms for adaptation to KRASG12D inhibitors
Abstract
It is well established that a population of single human cells will often respond to the same drug treatment in a heterogeneous manner. In the context of chemotherapeutics, these diverse responses may lead to individual adaptation mechanisms and ultimately multiple distinct methods of resistance. The obvious question from a pharmacology perspective is how intracellular concentrations of active drug varies between individual cells, and what role does that variation play in drug response heterogeneity? To date, no integrated methods for rapidly measuring intracellular drug levels while simultaneously measuring drug responses have been described. This study describes a method for single cell preparation that allows proteins to be extracted and digested from single cells while maintaining conditions for small molecules to be simultaneously measured. The method as described allows up to 40 cells to be analyzed per instrument per day. When applied to a KRASG12D small molecule inhibitor I observe a wide degree of intracellular levels of the drug, and that proteomic responses largely stratify based on the concentration of drug within each single cell. Further work is in progress to develop and standardize this method and - more importantly - to normalize drug measurements against direct measurements of cell volume. However, these preliminary results appear promising for the identification of single cells with unique drug response mechanisms. All data described in this study has been made publicly available through the ProteomeXchange consortium under accession PXD046002. Abstract graphic O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=171 SRC="FIGDIR/small/567669v1_ufig1.gif" ALT="Figure 1"> View larger version (49K): org.highwire.dtl.DTLVardef@11e5cfborg.highwire.dtl.DTLVardef@6a7dfborg.highwire.dtl.DTLVardef@1751923org.highwire.dtl.DTLVardef@c573a3_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- assay: proteomics
- research focus: cell type annotation
- research focus: drug response / drug discovery
- research focus: differential expression
- research focus: cell signaling & trafficking
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Metabolomic, proteomic and single cell proteomic analysis of cancer cells treated with the KRASG12D inhibitor MRTX1133
B. Orsburn·Journal of Proteome ResearchPeer-reviewed·Nov 20, 2023
- Defining and targeting adaptations to oncogenic KRASG12C inhibition using quantitative temporal proteomics
N. Santana-Codina, A. S. Chandhoke, … J. D. Mancias·bioRxiv·Sep 14, 2019
- Single Cell Chemical Proteomics (SCCP) Interrogates the Timing and Heterogeneity of Cancer Cell Commitment to Death
A. Vegvari, J. E. Rodriguez, R. Zubarev·bioRxiv·Apr 21, 2021
- Single cell proteomics of tumor compartments identifies differential kinase activities defining sensitivity to mTOR-PI3-kinase inhibition
N. M. Karabacak, Y. Zheng, … S. Maheswaran·bioRxiv·Jan 6, 2021
- Single-Cell Proteomic and Transcriptomic Characterization of Drug-Resistant Prostate Cancer Cells Reveals Molecular Signatures Associated with Morphological Changes
Jongmin Jacob Woo, Michael A. Loycano, … Hui Zhang·Molecular & Cellular ProteomicsPeer-reviewed·Mar 14, 2025
- Single-Cell Microwave Cytometry for Drug Resistance Detection in Cancer
Uzay Tefek, Hashim Z. Alhmoud, … M. Selim Hanay·bioRxiv·Jun 24, 2025